TrialBritish journal of clinical pharmacology2018

Results and evaluation of a first-in-human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods.

Stefan Sturm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.